Gregory Flesher
Directeur Général chez RENEO PHARMACEUTICALS, INC.
Fortune : 38 280 $ au 30/04/2024
Postes actifs de Gregory Flesher
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| RENEO PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 09/12/2020 | - |
| Directeur Général | 09/12/2020 | - | |
| President | 09/12/2020 | - | |
| Reneo Pharma Ltd. | Directeur/Membre du Conseil | - | - |
| Directeur Général | - | - | |
| President | - | - |
Historique de carrière de Gregory Flesher
Anciens postes connus de Gregory Flesher
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ADYNXX, INC. | Directeur/Membre du Conseil | 22/07/2019 | 01/06/2021 |
| ELEDON PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/05/2017 | 04/09/2020 |
| Directeur Général | 01/05/2017 | 04/09/2020 | |
| President | 01/05/2017 | 06/11/2017 | |
Otic Pharma Ltd.
 Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Directeur/Membre du Conseil | 27/07/2015 | 01/05/2017 |
| Directeur Général | 27/07/2015 | 01/05/2017 | |
| AVANIR PHARMACEUTICALS INC | Corporate Officer/Principal | 17/02/2011 | 01/01/2015 |
| INTERMUNE INC | Sales & Marketing | 01/01/2002 | 01/01/2006 |
Formation de Gregory Flesher
| Purdue University | Undergraduate Degree |
| The Indiana University School of Medicine | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 9 |
| Royaume-Uni | 2 |
Opérationnelle
| Director/Board Member | 5 |
| Chief Executive Officer | 4 |
| President | 3 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ELEDON PHARMACEUTICALS, INC. | Health Technology |
| ADYNXX, INC. | Health Technology |
| RENEO PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
Otic Pharma Ltd.
Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Health Technology |
| Reneo Pharma Ltd. |
- Bourse
- Insiders
- Gregory Flesher
- Expérience
